Si-ping Han

Company: Switch Therapeutics

Job title: Co-Founder & CTO

Seminars:

Panel Discussion – From Theory to Reality: Targeting Cancer with siRNA Therapeutics 2:15 pm

In the past year, siRNA therapeutics have rocketed as a widely promising potential therapy for several diseases. With the major shift of interest in oncology, it is critical to now consider the viability of targeting the tumors for therapeutic intervention & debate the important next steps to ensure siRNA cancer drugs become a reality Addressing…Read more

day: Day Two